S&P 500   4,245.01 (-0.67%)
DOW   33,357.90 (-0.78%)
QQQ   352.15 (-0.58%)
AAPL   169.60 (-1.37%)
MSFT   310.36 (-0.57%)
META   290.97 (-2.67%)
GOOGL   129.03 (+0.36%)
AMZN   125.05 (-0.74%)
TSLA   236.34 (-3.19%)
NVDA   418.22 (-0.21%)
NIO   8.36 (-0.59%)
BABA   85.69 (-0.26%)
AMD   97.07 (+1.16%)
T   14.83 (-1.26%)
F   12.29 (-1.13%)
MU   67.13 (-1.19%)
CGC   0.88 (-4.51%)
GE   110.41 (+0.44%)
DIS   79.46 (-0.74%)
AMC   7.67 (-3.03%)
PFE   32.03 (-1.14%)
PYPL   56.91 (-3.43%)
NFLX   376.81 (-0.64%)
S&P 500   4,245.01 (-0.67%)
DOW   33,357.90 (-0.78%)
QQQ   352.15 (-0.58%)
AAPL   169.60 (-1.37%)
MSFT   310.36 (-0.57%)
META   290.97 (-2.67%)
GOOGL   129.03 (+0.36%)
AMZN   125.05 (-0.74%)
TSLA   236.34 (-3.19%)
NVDA   418.22 (-0.21%)
NIO   8.36 (-0.59%)
BABA   85.69 (-0.26%)
AMD   97.07 (+1.16%)
T   14.83 (-1.26%)
F   12.29 (-1.13%)
MU   67.13 (-1.19%)
CGC   0.88 (-4.51%)
GE   110.41 (+0.44%)
DIS   79.46 (-0.74%)
AMC   7.67 (-3.03%)
PFE   32.03 (-1.14%)
PYPL   56.91 (-3.43%)
NFLX   376.81 (-0.64%)
S&P 500   4,245.01 (-0.67%)
DOW   33,357.90 (-0.78%)
QQQ   352.15 (-0.58%)
AAPL   169.60 (-1.37%)
MSFT   310.36 (-0.57%)
META   290.97 (-2.67%)
GOOGL   129.03 (+0.36%)
AMZN   125.05 (-0.74%)
TSLA   236.34 (-3.19%)
NVDA   418.22 (-0.21%)
NIO   8.36 (-0.59%)
BABA   85.69 (-0.26%)
AMD   97.07 (+1.16%)
T   14.83 (-1.26%)
F   12.29 (-1.13%)
MU   67.13 (-1.19%)
CGC   0.88 (-4.51%)
GE   110.41 (+0.44%)
DIS   79.46 (-0.74%)
AMC   7.67 (-3.03%)
PFE   32.03 (-1.14%)
PYPL   56.91 (-3.43%)
NFLX   376.81 (-0.64%)
S&P 500   4,245.01 (-0.67%)
DOW   33,357.90 (-0.78%)
QQQ   352.15 (-0.58%)
AAPL   169.60 (-1.37%)
MSFT   310.36 (-0.57%)
META   290.97 (-2.67%)
GOOGL   129.03 (+0.36%)
AMZN   125.05 (-0.74%)
TSLA   236.34 (-3.19%)
NVDA   418.22 (-0.21%)
NIO   8.36 (-0.59%)
BABA   85.69 (-0.26%)
AMD   97.07 (+1.16%)
T   14.83 (-1.26%)
F   12.29 (-1.13%)
MU   67.13 (-1.19%)
CGC   0.88 (-4.51%)
GE   110.41 (+0.44%)
DIS   79.46 (-0.74%)
AMC   7.67 (-3.03%)
PFE   32.03 (-1.14%)
PYPL   56.91 (-3.43%)
NFLX   376.81 (-0.64%)
NYSE:TFX

Teleflex (TFX) Price Target & Analyst Ratings

$194.70
-5.29 (-2.65%)
(As of 02:03 PM ET)
Compare
Today's Range
$194.13
$200.50
50-Day Range
$203.42
$258.85
52-Week Range
$182.65
$276.43
Volume
113,464 shs
Average Volume
306,711 shs
Market Capitalization
$9.15 billion
P/E Ratio
24.99
Dividend Yield
0.70%
Price Target
$268.92

Teleflex Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 12 Analyst Ratings

Consensus Analyst Price Target

$268.92
38.12% Upside
High Prediction$315.00
Average Prediction$268.92
Low Prediction$210.00
TypeCurrent
9/27/22 to 9/27/23
1 Month Ago
8/28/22 to 8/28/23
3 Months Ago
6/29/22 to 6/29/23
1 Year Ago
9/27/21 to 9/27/22
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
5 Buy rating(s)
5 Buy rating(s)
5 Buy rating(s)
Hold
7 Hold rating(s)
7 Hold rating(s)
7 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$268.92$268.92$273.38$322.70
Predicted Upside38.12% Upside16.95% Upside17.17% Upside15.28% Upside
Get Teleflex Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter.


TFX Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

TFX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Teleflex Stock vs. The Competition

TypeTeleflexMedical CompaniesS&P 500
Consensus Rating Score
2.42
2.66
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside37.63% Upside1,366.15% Upside699.19% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/7/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$264.00 ➝ $255.00+6.83%
8/7/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$272.00 ➝ $255.00+7.20%
8/4/2023JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$330.00 ➝ $315.00+31.54%
7/27/2023Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$305.00 ➝ $315.00+23.01%
7/19/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingEqual Weight ➝ Equal Weight$261.00+4.13%
6/21/2023Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
5/30/2023CL King
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$293.00+24.97%
4/26/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Peer Perform
4/18/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Petrone
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Target$220.00 ➝ $250.00-4.09%
10/28/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$342.00 ➝ $308.00+43.84%
10/28/2022Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$248.00 ➝ $229.00+6.23%
10/27/2022Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$265.00 ➝ $245.00+16.17%
10/12/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$210.00+9.93%
(Data available from 9/27/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












TFX Price Target - Frequently Asked Questions

What is Teleflex's consensus rating and price target?

According to the issued ratings of 12 analysts in the last year, the consensus rating for Teleflex stock is Hold based on the current 7 hold ratings and 5 buy ratings for TFX. The average twelve-month price prediction for Teleflex is $268.92 with a high price target of $315.00 and a low price target of $210.00. Learn more on TFX's analyst rating history.

Do Wall Street analysts like Teleflex more than its competitors?

Analysts like Teleflex less than other Medical companies. The consensus rating for Teleflex is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how TFX compares to other companies.

Does Teleflex's stock price have much upside?

According to analysts, Teleflex's stock has a predicted upside of 16.95% based on their 12-month price targets.

What analysts cover Teleflex?

Teleflex has been rated by JMP Securities, Morgan Stanley, Raymond James, Stephens, and Truist Financial in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:TFX) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -